Allergan Signs $750 Mln Settlement With Purchasers of Alzheimer ' s Drug Namenda Allergan Signs $750 Mln Settlement With Purchasers of Alzheimer ' s Drug Namenda

Purchasers of Allergan Plc ' s Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker conspired to keep generic versions of the Alzheimer ' s medication off the market.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news